Medicare Launches AI Payment Model for Chronic Care Agents

WASHINGTON: Medicare creates the first federal payment model designed specifically for AI agents managing chronic care in patient homes.

The Centers for Medicare and Medicaid Services launches the ACCESS model on July 5. ACCESS stands for Advancing Chronic Care with Effective, Scalable Solutions. The 10-year voluntary program rewards measurable health outcomes rather than required activities.

The model creates the first governmental reimbursement pathway for AI chronic care work. AI agents monitoring patients between visits now have a clear business model federally. Tasks include phone check-ins, housing referrals, and medication pickup coordination.

CMS selected 150 participants for the first cohort across the United States. Participants include AI doctor startups, virtual nutrition platforms, and traditional care providers. Pair Team announced its acceptance into the program on April 30.

Original Medicare will pay participants in fixed installments for managing chronic conditions. Full payment requires achieving measurable health gains in blood pressure or similar metrics. Target conditions include hypertension, diabetes, musculoskeletal pain, and depression.

The model targets a healthcare segment Silicon Valley has largely ignored historically. Chronic care management addresses some of Medicare’s most expensive patient populations. Traditional reimbursement rules previously prevented AI-driven approaches from scaling commercially.

“The government is creating swim lanes for AI innovation in traditionally regulated industries,” says Pair Team CEO Neil Batlivala.

The first cohort application deadline lands on May 15 for the July launch. Later applications target a January 2027 start date for additional participants. Participating organizations must enroll in Medicare Part B and meet compliance requirements.

The launch could unlock entirely new product categories across healthcare AI. Companies previously building agents without reimbursement now have clear federal revenue paths. Investors expect significant capital to follow the policy shift into healthcare AI startups.